Albireo Pharma, Inc. announces on January 3, 2022, Roger A. Jeffs, Ph.D, a member of the board of directors of the company, resigned effective as of January 3, 2022 to pursue other opportunities.
Albireo Pharma, Inc.
Equities
ALBO
US01345P1066
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
-3.39% | 102B | |
+2.61% | 96.84B | |
-1.11% | 21.48B | |
-18.14% | 20.82B | |
-7.35% | 18.6B | |
-40.70% | 16.81B | |
-26.89% | 13.78B | |
+1.12% | 13.4B | |
+22.25% | 11.06B |